(Q33343961)

English

Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

deep vein thrombosis

1 reference

based on heuristic

inferred from title

Edelgard Lindhoff-Last

1

object named as

Edelgard Lindhoff-Last

0 references

author name string

Edelgard Lindhoff-Last

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Roumen Nakov

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Frank Misselwitz

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hans-Klaus Breddin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rupert Bauersachs

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1137-1142

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Heparin-induced thrombocytopenia: an under-diagnosed syndrome? Proceedings of a workshop held in London on 1 November 1996. Consensus overview

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Heparin-related thrombosis despite normal platelet counts in vascular surgery

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03687.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2002.03687.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33343961&oldid=1957697053"